Estrogen a more powerful breast cancer culprit than we realized
May 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
What's New in Breast Cancer - Susan G. Komen®
Learn about new breast cancer treatment breakthroughs and recent developments in research that are fueling new ways to assess risk, prevent, detect and diagnose breast cancer.
Breast cancer deaths in the US continue to fall, but new report …
Oct 1, 2024 · The study, published Tuesday in CA: A Cancer Journal for Clinicians, found some good news: The overall breast cancer death rate in the US dropped about 44% between 1989 and 2022, which...
New study finds triple-negative breast cancer tumors with an …
Apr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not …
Breast Cancer News - ScienceDaily
Oct 22, 2024 · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
Breast cancer - Latest research and news | Nature
Oct 30, 2024 · Breast cancer articles from across Nature Portfolio. Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk...
FDA expands approval of breast cancer drug Kisqali to ... - NBC News
Sep 17, 2024 · The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. The drug was found to reduce the risk of a patient's...
Research News - Breastcancer.org
Oct 23, 2024 · Breast Cancer 10-Year Recurrence Risk Linked to Estrogen Receptor Status, Other Factors. The risk of early-stage breast cancer coming back after 10 years is linked to a number of factors, including whether the cancer is estrogen receptor-positive. Nov 30, 2021 | Diagnosis and Hormonal Therapy.
Breast cancer metastasis on/off switch revealed - Stanford News
December 20th, 2023 | 5 min read Science & Engineering. Researchers uncover on/off switch for breast cancer metastasis. New research from Stanford and the Arc Institute could lead to a new and more effective immunotherapy and help clinicians better predict patient response to …
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
Jun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...